Monopar Appoints Jeffrey D. Kent, M.D., as Executive Vice President, Head of Medical Affairs; Announces Two ALXN1840 Presentations at AASLD – The Liver Meeting® 2026
Go back to Monopar Appoints Jeffrey D. Kent, M.D., as Executive Vice President, Head of Medical Affairs; Announces Two ALXN1840 Presentations at AASLD – The Liver Meeting® 2026| (NASDAQ: MNPR) | Delayed: 114.38 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $114.38 | 52 Week High | $ | |||
| Open | $114.38 | 52 Week Low | $ | |||
| Day High | $114.38 | P/E | N/A | |||
| Day Low | $114.38 | EPS | $ | |||
| Volume | 4,108 | |||||

